Artelo Biosciences, Inc. (ARTL)
3.24
-1.61
(-33.20%)
USD |
NASDAQ |
Mar 26, 11:30
Artelo Biosciences Free Cash Flow : -8.787M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Ironwood Pharmaceuticals, Inc. | 127.01M |
| Ovid Therapeutics, Inc. | -38.33M |
| Gossamer Bio, Inc. | -171.34M |
| ACADIA Pharmaceuticals, Inc. | 6.308M |
| Alnylam Pharmaceuticals, Inc. | 465.38M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -2.919M |
| Cash from Investing (Quarterly) | 0.1976M |
| Cash from Financing (Quarterly) | 1.580M |
| Free Cash Flow Per Share (Quarterly) | -3.950 |
| Free Cash Flow to Equity (Quarterly) | -2.382M |
| Free Cash Flow to Firm (Quarterly) | -2.564M |
| Free Cash Flow Yield | -246.1% |